Abstract
Approximately 30% of COVID-19 cases may experience chronic symptoms, known as post-COVID-19 syndrome (PCS). Common PCS symptoms can include fatigue, cognitive impairment, and persistent physical, neurological, and neuropsychiatric complaints. To improve healthcare and management of the current and future pandemics, we highlight the need for establishing interdisciplinary post-viral outpatient clinics comprised of specialists in fields such as psychiatry, psychotherapy, neurology, cardiology, pneumology, and immunology. In this way, PCS patients with a high health burden can receive modern diagnostics and targeted therapeutic recommendations. A key objective is to distinguish the “sick recovered” from the “healthy recovered.” Our hypothesis is that there is a PCS subgroup with autoimmune-mediated systemic and brain-vascular dysregulation, which may lead to circulatory disorders, fatigue, cognitive impairment, depression, and anxiety. This can be clarified using a combination of specific antibody diagnostics and precise clinical, psychological, and apparative testing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
COVID-19 Coronavirus Pandemic. https://www.worldometers.info/coronavirus/. Accessed August 26, 2022
COVID-19 Cumulative Infection Collaborators (2022) Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. Lancet 399(10344):2351–2380
Davis A (2022) COVID Evaluation Model Estimates 57 Percent of World Population Infected at Least Once. https://www.newsweek.com/covid-evaluation-model-estimates-57-percent-world-population-infected-least-once-1672440. Accessed August 26, 2022
Pulliam JRC, van Schalkwyk C, Govender N, et al (2022) Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science 376(6593):eabn4947. https://doi.org/10.1126/science.abn4947
Phan TT, Nguyen TB, Phung QT, et al (2022) Incidence of SARS-CoV-2 Infection during the Omicron Variant Emergence in Southern Vietnam: Prior Infection versus Third-Dose Vaccination. Microbiol Spectr; Aug 24:e0117522. https://doi.org/10.1128/spectrum.01175-22
Achenbach J (2022) As the BA.5 variant spreads, the risk of coronavirus reinfection grows. https://www.washingtonpost.com/health/2022/07/10/omicron-variant-ba5-covid-reinfection/
Keane D (2022) How likely am I to be reinfected with Covid and do Omicron BA.4 and BA.5 have different symptoms? Evening Standard; July 11. https://www.standard.co.uk/news/uk/covid-how-likely-reinfected-ba4-ba5-omicron-variant-symptoms-b1011555.html
Tenforde MW, Kim SS, Lindsell CJ, et al (2020) Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network – United States, March-June 2020. MMWR Morb Mortal Wkly Rep 69(30):993–998
Huang Y, Pinto MD, Borelli JL, et al (2021) COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler: Looking for Clarity in the Haze of the Pandemic. medRxiv 2021.03.03.21252086. https://doi.org/10.1101/2021.03.03.21252086
National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP) (2022) March 01; COVID-19 rapid guideline: managing the long-term effects of COVID-19. https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742. Accessed August 26, 2022
A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. World Health Organization. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. Accessed April 06, 2022
Renaud-Charest O, Lui LMW, Eskander S, et al (2021) Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. J Psychiatr Res 144:129–137
Nalbandian A, Sehgal K, Gupta A, et al (2021) Post-acute COVID-19 syndrome. Nat Med 27(4):601–615
Ceban F, Ling S, Lui LMW, et al (2022) Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun 101:93–135
Sacchi MC, Tamiazzo S, Stobbione P, et al (2021) SARS-CoV-2 infection as a trigger of autoimmune response. Clin Transl Sci 14(3):898–907
Acosta-Ampudia Y, Monsalve DM, et al (2022) Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome. J Infect Dis 225(12):2155–2162
Seeßle J, Waterboer T, Hippchen T, et al (2022) Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clin Infect Dis 74(7):1191–1198
Dotan A, Muller S, Kanduc D, et al (2021) The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev 20(4):102792. https://doi.org/10.1016/j.autrev.2021.102792
Vasilevska V, Guest PC, Bernstein HG, et al (2021) Molecular mimicry of NMDA receptors may contribute to neuropsychiatric symptoms in severe COVID-19 cases. J Neuroinflammation 18(1):245. https://doi.org/10.1186/s12974-021-02293-x
Kim D, Lee JY, Yang JS, et al (2020) The Architecture of SARS-CoV-2 Transcriptome. Cell 181(4):914–921.e10. https://doi.org/10.1016/j.cell.2020.04.011
Jamison DA Jr, Anand Narayanan S, Trovão NS, et al (2022) A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection. Eur J Hum Genet 30(8):889–898
Rashid F, Xie Z, Suleman M, et al (2022) Roles and functions of SARS-CoV-2 proteins in host immune evasion. Front Immunol 13:940756. https://doi.org/10.3389/fimmu.2022.940756
Rohaim MA, El Naggar RF, Clayton E, Munir M (2021) Structural and functional insights into non-structural proteins of coronaviruses. Microb Pathog 150:104641. https://doi.org/10.1016/j.micpath.2020.104641
Sun G, Xue L, He Q, et al (2021) Structural insights into SARS-CoV-2 infection and therapeutics development. Stem Cell Res 52:102219. https://doi.org/10.1016/j.scr.2021.102219
Gordon DE, Jang GM, Bouhaddou M, et al (2020) A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583(7816):459–468
Alexandersen S, Chamings A, Bhatta TR (2020) SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication. Nat Commun 11(1):6059. https://doi.org/10.1038/s41467-020-19883-7
Yapici-Eser H, Koroglu YE, Oztop-Cakmak O, et al (2021) Neuropsychiatric Symptoms of COVID-19 Explained by SARS-CoV-2 Proteins’ Mimicry of Human Protein Interactions. Front Hum Neurosci 15:656313. https://doi.org/10.3389/fnhum.2021.656313
Nunez-Castilla J, Stebliankin V, Baral P, et al (2022) Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins. Viruses 14(7):1415. https://doi.org/10.3390/v14071415
Zuo Y, Estes SK, Ali RA, et al (2020) Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med 12(570):eabd3876. https://doi.org/10.1126/scitranslmed.abd3876
Emmenegger M, Kumar SS, Emmenegger V, et al (2021) Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins. PLoS Pathog 17(12):e1010118. https://doi.org/10.1371/journal.ppat.1010118
Narula S, Winkle S, Brand K, et al (2021) Hyperhemolysis in the Setting of Mixed-Autoimmune Hemolytic Anemia: A Rare Complication of COVID-19. Cureus 13(12):e20356. https://doi.org/10.7759/cureus.20356
Shi H, Zuo Y, Navaz S, Harbaugh A, et al (2022) Endothelial Cell-Activating Antibodies in COVID-19. Arthritis Rheumatol 74(7):1132–1138
Singh B, Kaur P, Maroules M (2021) Autoimmune Hepatitis-Primary Biliary Cholangitis Overlap Syndrome Triggered by COVID-19. Eur J Case Rep Intern Med 8(3):002264. https://doi.org/10.12890/2021_002264
de Vries MP, Mohammadnia N, Simsek S, Schoorl M (2022) Eosinopenia and increased markers of endothelial damage are characteristic of COVID-19 infection at time of hospital admission. Scand J Clin Lab Invest 82(4):290–295
Kayser MS, Dalmau J (2016) Anti-NMDA receptor encephalitis, autoimmunity, and psychosis. Schizophr Res 176(1):36–40
Varatharaj A, Thomas N, Ellul MA, et al (2020) Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry 7(10):875–882
Douaud G, Lee S, Alfaro-Almagro F, et al (2022) SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604(7907):697–707
Miedema J, Schreurs M, van der Sar-van der Brugge S, et al (2021) Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course. Front Immunol 12:684142. https://doi.org/10.3389/fimmu.2021.684142
Cabral-Marques O, Halpert G, Schimke LF, et al (2022) Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity. Nat Commun 13(1):1220. https://doi.org/10.1038/s41467-022-28905-5
Wallukat G, Hohberger B, Wenzel K, et al (2021) Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun 4:100100. https://doi.org/10.1016/j.jtauto.2021.100100
Szewczykowski C, Mardin C, Lucio M, et al (2022) Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation. Int J Mol Sci 23(13):7209. https://doi.org/10.3390/ijms23137209
Bayram N, Gundogan M, Ozsaygılı C, Adelman RA (2022) Posterior ocular structural and vascular alterations in severe COVID-19 patients. Graefes Arch Clin Exp Ophthalmol 260(3):993–1004
Tsokolas G, Tsaousis KT, Diakonis VF, et al (2020) Optical Coherence Tomography Angiography in Neurodegenerative Diseases: A Review. Eye Brain 12:73–87
Augustin AJ, Atorf J (2022) The Value of Optical Coherence Tomography Angiography (OCT-A) in Neurological Diseases. Diagnostics (Basel) 12(2):468. https://doi.org/10.3390/diagnostics12020468
POTS/Long Covid-diagnostics; CellTrend; https://www.celltrend.de/en/pots-cfs-me-sfn/. Accessed September 4, 2022
EUROIMMUN Autoantibodies in neurological diseases. https://www.euroimmun.com/documents/Indications/Autoimmunity/Neurology/MAG_myelin_GAD/FA_1111_I_UK_A.pdf
Dingerman T (2022) Is an active substance against Long Covid in sight? https://www.pharmazeutische-zeitung.de/ist-ein-wirkstoff-gegen-long-covid-in-sicht-128192/#:~:text=Vier%20Long%20Covid%2DPatienten%20konnten,klinische%20Studie%20steht%20noch%20aus
Brodde OE, Hillemann S, Kunde K, et al (1992) Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure. J Heart Lung Transplant 11(4 Pt 2):S164–74
Salazar NC, Chen J, Rockman HA (2007) Cardiac GPCRs: GPCR signaling in healthy and failing hearts. Biochim Biophys Acta 1768(4):1006–1018
Hohberger B (2021) Results of first successful treatment confirmed with two other Long COVID patients. https://www.fau.eu/2021/08/27/news/research/further-patients-benefit-from-drug-against-long-covid/
Tzilas V, Manali E, Papiris S, Bouros D (2020) Intravenous Immunoglobulin for the Treatment of COVID-19: A Promising Tool. Respiration 99(12):1087–1089
Danieli MG, Piga MA, Paladini A, et al (2021) Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease. Scand J Immunol 94(5):e13101. https://doi.org/10.1111/sji.13101
Bornstein SR, Voit-Bak K, Donate T, et al (2022) Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis? Mol Psychiatry 27(1):34–37
Robert Koch-Institut: COVID-19-Dashboard. Evaluations based on the reporting data transmitted from the health authorities in accordance with IfSG. https://experience.arcgis.com/experience/478220a4c454480e823b17327b2bf1d4. Accessed April 06, 2022
Whitaker M, Elliott J, Chadeau-Hyam M, et al (2022) Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun 13(1):1957. https://doi.org/10.1038/s41467-022-29521-z
Post-COVID-19 Ambulances; LONG COVID GERMANY. https://longcoviddeutschland.org/ambulanzen/. Accessed April 06, 2022
Steiner J, Prüss H, Köhler S, et al (2020) Autoimmune encephalitis with psychosis: Warning signs, step-by-step diagnostics and treatment. World J Biol Psychiatry 21(4):241–254
Pollak TA, Lennox BR, Müller S, et al (2020) Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry 7(1):93–108
Kayser MS, Dalmau J (2011) The emerging link between autoimmune disorders and neuropsychiatric disease. J Neuropsychiatry Clin Neurosci 23(1):90–97
Zhao S, Tran VH (2022) Postural Orthostatic Tachycardia Syndrome. [Updated 2021 Aug 11]. In: StatPearls [Internet]. Treasure Island, FL, USA. https://www.ncbi.nlm.nih.gov/books/NBK541074/ (accessed October 10, 2022)
Arnson Y, Shoenfeld Y, Alon E, Amital H (2010) The antiphospholipid syndrome as a neurological disease. Semin Arthritis Rheum 40(2):97–108
Man YL, Sanna G (2022) Neuropsychiatric Manifestations of Antiphospholipid Syndrome-A Narrative Review. Brain Sci 12(1):91. https://doi.org/10.3390/brainsci12010091
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Guest, P.C. et al. (2023). A Molecular Biomarker-Based Triage Approach for Targeted Treatment of Post-COVID-19 Syndrome Patients with Persistent Neurological or Neuropsychiatric Symptoms. In: Guest , P.C. (eds) Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19. Advances in Experimental Medicine and Biology(), vol 1412. Springer, Cham. https://doi.org/10.1007/978-3-031-28012-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-031-28012-2_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-28011-5
Online ISBN: 978-3-031-28012-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)